CHINA Cdc Corp. (MM)

CDC Corporation (NASDAQ: CHINA),a leading China-based value-added operator of, and growth investor in, hybrid (SaaS/On-Premise) enterprise software, IT Services, and New Media assets, today announced financial results for the quarter ended December 31, 2010. For the fourth quarter of 2010, operating cash flow increased 65 percent to $8.9 million, compared to $5.4 million in the fourth quarter of 2009. In addition, CDC Corporation ended fiscal year 2010 with Non-GAAP cash and cash equivalents(a) of approximately $111.8 million.

For the fourth quarter of 2010, CDC Corporation reported Non-GAAP revenue(a) of $83.9 million and Adjusted EBITDA(a) of $6.5 million, compared to Non-GAAP revenue of $83.6 million and Adjusted EBITDA of $12.8 million for the fourth quarter of 2009.

For the year ended December 31, 2010, Non-GAAP revenue was $322.5 million and Adjusted EBITDA was $31.0 million, compared to Non-GAAP revenue of $320.8 million and Adjusted EBITDA of $41.5 million for the full year in 2009. In the fourth quarter of 2010, the company recorded non-cash restructuring charges of approximately $17.5 million related to goodwill impairment, litigation and other restructuring related expenses. Excluding certain non-cash, restructuring and other charges of $51.3 million, as depicted herein, CDC Corp reported $31.0 million of adjusted EBITDA for the 2010.

“We are very pleased with our strong operating cash flow which increased 65 percent in the fourth quarter of 2010, compared to the prior year period,” said Peter Yip, CEO of CDC Corporation. “With the many forward-thinking strategies we have in place, we believe we are well positioned for long-term growth and improved shareholder returns. For instance, CDC Software’s cash flow from continuing operations rose 99 percent in the fourth quarter of 2010, compared to the fourth quarter of 2009. CDC Software also reported strong growth in its Cloud segment in the fourth quarter 2010. Also, our focus on profitability and growth at CDC Games has paid off. CDC Games reported a 40 percent Adjusted EBITDA margin in the fourth quarter of 2010 compared to a 7 percent Adjusted EBITDA margin in the fourth quarter of 2009, and an impressive 480 percent increase in Adjusted EBITDA in the fourth quarter of 2010, compared to the fourth quarter of 2009. Our strategy on controlling expenses in such a competitive games market has clearly been effective. CDC Global Services has also continued to invest significantly in its offshore development business in China which it believes is a market that will experience rapid growth in the next few years. Further validating our value-added investment approach, China.com has invested in a China-based private equity fund whose audited results as of December 31, 2010, indicates that it has achieved a return multiple of approximately 4 times(c). This investment is accounted for under the cost basis of accounting, therefore, the return is not reflected fully in our financial statements. As a result of this superior performance, we are planning more co-investments with this PE Fund and potential partnerships with its investees in China.”

Below is a summary of the financial results of CDC Corporation’s core portfolio of assets.

CDC Software (NASDAQ:CDCS)

On a standalone basis, CDC Software had the following results for the three months ended December 31, 2009 and 2010:

   

Q4 2009

Q4 2010

Non-GAAP revenue $55.0 million $57.6 million Adjusted EBITDA $14.1 million $9.0 million Adjusted EBITDA Margin 26% 16%  

Operating cash flow in the fourth quarter of 2010 was $13.3 million, and GAAP cash and cash equivalents were $44.7 million as of December 31, 2010.

Application sales increased 22 percent to $14.6 million in the fourth quarter of 2010, compared to $12.0 million in the fourth quarter of 2009. Application sales are comprised of license revenue plus Secured Total Contract Value (STCV) for Software-as-a-Service (SaaS) sales secured during the quarter. The strong growth in application sales was primarily due to significant growth in the company’s cloud segment, especially within its CDC gomembers product line, and the inclusion of CDC TradeBeam. Fourth quarter 2010 Total Contracted Backlog (TCB) was $136.5 million, compared to $104.4 million in the fourth quarter of 2009. TCB is the sum of the remaining revenue value of SaaS and term license or rental contracts through the end of their respective terms, the value of contracted renewals for current SaaS and rental contracts based on 12 months of value, plus maintenance revenues from existing on-premise contracts over the previous 12 months.

“Overall, we are pleased with our top line growth at CDC Software that included a 22 percent growth in application sales and a 99 percent increase in cash flow from operations in the fourth quarter 2010, over the fourth quarter of 2009,” said Bruce Cameron, president of CDC Software. “Our CDC TradeBeam and CDC gomembers cloud products reported strong sales growth during the fourth quarter of 2010. The fourth quarter of 2010 was also highlighted by numerous new logo sales and we have been seeing positive results from the company’s focus on sales in emerging regions, with strong sales growth in Latin America, China and India.

“We believe the market for our cloud solutions will experience significant growth over the next few years. Looking ahead, based upon current financial projections and estimates, we expect record Non-GAAP revenue and total SaaS secured bookings to be approximately $6.7 million in the first quarter of 2011; the highest level since the company started its cloud business in the fourth quarter of 2009.”

For more information regarding the financial performance of CDC Software during the fourth quarter of 2010, please see CDC Software's fourth quarter 2010 earnings press release located at the company's website: www.cdcsoftware.com.

CDC Global Services

On a standalone basis, CDC Global Services had the following results for the three months ended December 31, 2009 and 2010:

   

Q4 2009

Q4 2010

GAAP Revenue: $17.6 million $14.6 million Adjusted EBITDA: $(0.1) million $(1.4) million Adjusted EBITDA Margin: 0% (9)%  

Some highlights in the CDC Global Services business during the fourth quarter of 2010 include:

• The company completed the construction of its Nanjing Global Delivery Center (GDC) in December. This GDC is expected to serve CDC Global Services’ international clients with offshore software development work.
• Another GDC is being planned in the city of Nanhai where CDC Global Services has been chosen as the solution provider to run Nanhai’s Cloud Computing Center.
• CDC Global Services’ Technical Services Practice of the China Division has been asked to further expand the SAP consulting team assigned to work on the National Grid project.
• The company’s North America Division has successfully restructured and streamlined three of its consulting operations in the cities of Chicago, Portland and Philadelphia to report to one management team for improved operational efficiency.
• The Australia Division has further expanded its Information Security consulting and audit practice. Three leading Australian banks have engaged CDC Global Services to provide PCI Compliance services.
• Appointment of Derik Reynecke as Chief Financial Officer of CDC Global Services. Reynecke brings extensive M&A, capital markets, public accounting and financial expertise to the business.
• Appointment of Tek-Min Gan as Vice President of Operations, who will be responsible for managing CDC Global Services’ offshore development center business.

CDC Global Services has been expanding its operations and leveraging its influence in the China market. Most notably, it recently signed a memorandum of understanding with the China Merchant Group Zhangzhou Economic and Technology Development Zone to invest in the setup of a center in Zhangzhou to develop IT solutions supporting the food processing industry in China.

As part of this partnership, CDC Global Services and the Zhangzhou government also plan to host an international IT Food application seminar in Zhangzhou in the second quarter of 2011. This seminar will feature thought leadership sessions in IT food manufacturing solutions, food safety and other industry trends for multinational companies in China, local businesses, academic and government officials and international customers seeking to expand into the China market. This event marks the launch of CDC Global Services “Silk Road” business consulting services. This service offering is named after the network of trade routes used by early century travelers and traders to connect the Asian continent with Europe and parts of Africa. This collection of “Silk Road” services is planned to help customers facilitate and streamline access into China, as well as effectively operate in this fast growing market.

“We have been making steady progress in expanding the services provided by the Global Delivery Centers that we have established in China and India,” said CK Wong, CEO of CDC Global Services. “As result, our profitability has been temporarily impacted by our investments in our GDC and increase in management staff for our offshore development center business. Last year was one of transition and now we are focused as a China-centric outsourcing and consulting company with market presence largely in the U.S. and Australia. We also are focusing on our higher margin business and we expect to see better traction and improvement in 2011. We believe we are laying a solid foundation to fully exploit the significant future revenue opportunities in our GDC offerings. CDC Global Services also has plans to manage new cloud computing centers in China and to connect them with the Nanhai, Foshan Computing Center.”

“We have also been laying the ground work for opening up opportunities in China for CDC Global Services and other CDC Corporation businesses,” Wong added. “Several of CDC Corporation’s businesses have deep connections and core operations within China, as well as its management team and Board of Directors share many key relationships within China. As a result, we are executing a strategy called “Silk Road” to become a partner of choice for investors and companies seeking to do business or expand operations there. Finally, we believe the addition of Reynecke and Gan to our senior management team is very timely, and they will help us increase revenue opportunities and improve profitability throughout CDC Global Services’ business.”

New Media (includes CDC Games and China.com)

On a standalone basis, CDC Games had the following results for the three months ended December 31, 2009 and 2010:

   

Q4 2009

Q4 2010

GAAP Revenue: $7.0 million $7.3 million Adjusted EBITDA: $0.5 million $2.9 million Adjusted EBITDA Margin: 7% 40%  

GAAP revenue for CDC Games during the fourth quarter of 2010 increased to $7.3 million, compared to $7.0 million in the fourth quarter of 2009. Adjusted EBITDA for the fourth quarter of 2010 increased 480 percent to $2.9 million, compared to Adjusted EBITDA of $0.5 million in the fourth quarter of 2009, primarily due to the implementation of cost-cutting measures and streamlining of operations. Adjusted EBITDA margin was 40 percent in the fourth quarter of 2010, compared to Adjusted EBITDA margin of 7 percent in the fourth quarter of 2009.

Recently, CDC Games extended its contract with Mgame to continue operating Yulgang for two additional years. Yulgang, its flagship game, has continued to report strong metrics, and reported a 27 percent increase in revenue for the fourth quarter of 2010, compared to the third quarter of 2010. For 2011, CDC Games expects to commercially launch the previously announced domestic game called Mythical Legend, with plans to launch another game this year, as well.

CDC Games has been experiencing continued delays with The Lord of the Rings Online (LOTRO), a massively multiplayer online role playing game (MMORPG) based on the literary works of J.R.R. Tolkien. LOTRO is developed by North American-based Turbine, Inc., a subsidiary of Warner Bros. Home Entertainment Group. CDC Games continues to work with Turbine/Warner Bros. with respect to the terms of our agreement with Turbine and to come to terms on making this free-to-play version ready for success in the market.

“We are pleased with the significant improvement in our profitability that will allow us to invest in new games,” said Simon Wong, CEO of CDC Games. “We are excited with the renewal of our contract with Mgame and expect that Yulgang will continue to generate strong revenue metrics, especially with a major new update of the game expected later this year. Since the China games market is increasingly becoming more competitive, we want to ensure LOTRO’s launch runs smoothly and is best positioned for success. As a result, we are continuing to work with Turbine to launch this game when it is ready.”

On a standalone basis, China.com had the following results for the three months ended December 31, 2009 and 2010:

    Q4 2009 Q4 2010 GAAP Revenue: $4.1 million $4.4 million Adjusted EBITDA: $0.8 million $0.4 million

Adjusted EBITDA Margin:

20%

10%

 

GAAP revenue for the fourth quarter of 2010 was $4.4 million, compared to $4.1 million in the fourth quarter of 2009. China.com reported Adjusted EBITDA of approximately $0.4 million in the fourth quarter of 2010, compared to Adjusted EBITDA of approximately $0.8 million in the fourth quarter of 2009.

During the fourth quarter of 2010, China.com’s Portal business continued to expand its automobile and web games channels, and added some major global brand clients including some of the world’s largest car manufacturers. China.com’s TTG business also improved its revenue and profitability, and organized three major events in the fourth quarter of 2010.

As previously announced, China.com, Inc.’s investment in a Beijing-based private equity fund from which it has received approximately $3.0 million in distributions since 2009, has produced significant returns.

Minority Interest Investments

CDC Corporation’s other investment strategy includes identifying and executing on opportunities to co-invest with leading venture capital and private equity funds through minority interests in fast growth companies in emerging markets related to CDC Corporation’s core assets.

Below is a brief snapshot of one of CDC Corporation’s minority-interest investments:

• Menue (formerly Bbmf) is one of the largest independent operators of 3G comics in Japan. CDC Corporation holds a 20 percent equity interest in this company. The company also recently launched operations in the U.S. For the first quarter of 2011, Menue reported over 92 million free and paid comic book downloads, of which 30 percent was paid subscribers, across the company’s comic services on feature phones and smart phones, a 15 percent increase from 80 million downloads from the first quarter of 2010. Menue launched its Android comic service in February and has seen 400 percent month over month growth in free and paid comic book downloads from February 2011 to March 2011.

Update on Evolution Capital Management

In February 2011, CDC Corporation sought permission to file a Restated Second Amended Complaint against Evolution Capital Management and its affiliates. CDC’s new proposed Complaint seeks to add various Evolution directors as defendants and provides additional insight into the facts supporting CDC’s claims. The proposed Complaint also increases the amount of damages CDC is seeking to at least $795 million, which includes $295 million in compensatory damages and $500 million in punitive damages.

In March 2011, Evolution and its affiliates withdrew their pending Motion to Amend their Complaint, which had sought to add CDC Software International, CDC Software Corporation and CDC Delaware Corporation as defendants.

CDC plans to file a Motion for Summary Judgment in the Evolution CDC SPV Ltd v. CDC Corporation litigation on April 21, 2011, arguing that discovery in the matter has revealed no disputed issues of material fact and that CDC is therefore entitled to immediate judgment in its favor.

Share Buyback

During 2010 and 2011, CDC Corporation purchased a total of 1.3 million of its shares at an average price of $4.91 per share.

Concluding Remarks

”In the fourth quarter of 2010, many of our businesses continued to make significant investments in their operations to position for growth in rapidly growing markets,” Mr. Yip concluded. “This has impacted profitability in the short term, but we believe we are well positioned for future growth and to deliver maximum value to shareholders. We believe the number of strategic initiatives and investments we have made in the China market will allow us to operate as a value-added investor and operator, co-investing with and operating jointly with trading and long term strategic and private equity partners inside and outside of China. We believe that our strategies also will allow us to continue to focus on our core competency in vertical industries such as food/life science, manufacturing, financial services, global supply chain, and interactive games/mobile/new media. Our recent partnership with the China Merchant Group, and the related upcoming Food Conference, are just recent examples of how we have been advancing our Silk Road strategy to position CDC Global Services and our other businesses for growth.

“We have taken the prudent approach to cleaning up our balance sheet in accordance to U.S. GAAP rules by recording various non-cash Non-GAAP write downs and impairments for the year ended December 31, 2010. Finally, we do not believe CDC’s current market valuation is reflective of the company’s actual core asset value, and as such, we plan to recommend to our Board that the company continues to buy CDC Corporation shares when and if trading windows are opened.”

Conference Call

The company's senior management will host a conference call for financial analysts and investors on April 21, 2011 at 8:30AM EDT.

USA-based Toll Free Number: +1 866 903-3296

International: +1 706 643-6263

Passcode: #:47911441

Call Leader: Monish Bahl

Investors are invited to listen to a live webcast of the conference call which can be accessed through the investor section of the CDC Corporation website at www.cdccorporation.net. The call can also be accessed through www.streetevents.com. To listen to the call, please go to the website at least 15 minutes prior to the call and download any necessary audio software.

Instant Replay

For those unable to call in, a digital instant replay will be available after the call until May 5, 2011. U.S. based Toll Free Number: +1 800 642 1687, U.S.-based Toll Number: +1 706 645 9291 Passcode or PIN #: 47911441

Footnotes:

All dollar amounts are in U.S. dollars

* CDC Corporation has recently changed the composition of its Adjusted EBITDA measurement, as provided herein, to be consistent with the presentation of Adjusted EBITDA for its subsidiary, CDC Software Corporation. CDC Corporation believes this revised presentation is a useful measure of operating performance.

(a) Adjusted Financial Measures

This press release includes Adjusted EBITDA, Non-GAAP revenue, Non-GAAP cash and cash equivalents, and Adjusted EBITDA margin, which are not prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) (collectively, the "Non-GAAP Financial Measures"). We believe that these Non-GAAP Financial Measures are helpful in understanding our past financial performance and our future results. Non-GAAP Financial Measures are not alternatives for measures such as revenue, cash and cash equivalents and other measures prepared under GAAP. These Non-GAAP Financial measures may also be different from Non-GAAP measures used by other companies. Non-GAAP Financial Measures should not be used as a substitute for, or considered superior to, measures of financial performance prepared in accordance with GAAP.

Investors should be aware that these Non-GAAP Financial Measures have inherent limitations, including their variance from certain of the financial measurement principals underlying GAAP, should not be considered as a replacement for GAAP performance measures, and should be read in conjunction with our consolidated financial statements prepared in accordance with GAAP. These supplemental Non-GAAP Financial Measures should not be construed as an inference that the Company's future results will be unaffected by similar adjustments to net earnings determined in accordance with GAAP. Reconciliations of Non-GAAP Financial Measures to GAAP are provided herein immediately following the financial statements included in this press release.

(b) Revised Information

Results provided herein for 2009 may be different than those previously reported in our press releases due to certain year-end adjustments required to be made in connection with the audit of our financial statements for the year ended December 31, 2009. Amounts presented herein for 2010 are unaudited and may change in connection with the audit of the company’s financial statements for the year ended December 31, 2010.

(c) The management, operation, policy and conduct of the PE Fund is vested exclusively in its general partners. China.com is a limited partner in the PE Fund and has accounted for its investment in the PE Fund at cost less any impairments, because the range of reasonable fair value estimates is so significant that the directors of China.com are of the opinion that their fair value cannot be measured reliably. China.com’s remaining commitment in the PE Fund is approximately (USD)$2.0 million. The timing of any capital contributions is generally on an “as needed” basis. The term of the PE Fund is seven years ending in 2014 unless terminated earlier pursuant to the partnership agreement.

About CDC Corporation

CDC Corporation is a China-based value-added operator of, and growth investor in, hybrid (on premise and SaaS) enterprise software, IT, and new media businesses. The company pursues two value-added investment strategies. The first strategy includes actively managing majority interests in its core portfolio of hybrid enterprise software, IT services and New Media businesses, adding value by driving operational excellence, top-line growth and overall profitability. The third strategy includes identifying and executing on opportunities to co-invest with leading venture capital and private equity funds through minority interests in fast growth companies in emerging markets related to CDC Corporation’s core assets. This third strategy, which complements the first, helps to mitigate risk and enhance deal flow for the company. CDC Corporation expects to deliver superior returns and additional value for its shareholders through these strategies, as well as through its plans to declare and pay regular dividends in the form of registered shares of its publicly listed subsidiaries and other assets. For more information about CDC Corporation (NASDAQ: CHINA), please visit www.cdccorporation.net.

Cautionary Note Regarding Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include statements regarding our beliefs about our position for long-term growth, our expectations with respect to revenue amounts from CDC Software’s cloud business for any future period, our beliefs regarding the offshore development business in China and the growth potential thereof, our beliefs and expectations for returns on China.com’s investment in the Beijing-based private equity fund, our plans with respect to additional co-investments with the PE Fund and potential partnerships with its investees, our beliefs regarding potential growth in the cloud market over the next few years, our expectations with respect to Non-GAAP revenue and total SaaS secured bookings in the first quarter of 2011, our expectations regarding the Nanjing Global Delivery Center, our plans with respect to a Global Delivery Center in Nanhai, our expectations regarding the Zhangzhou food conference in the second quarter of 2011, our beliefs regarding our foundation to exploit future revenue opportunities at CDC Global Services, our plans to manage new cloud computing centers in China, our beliefs regarding new members of management at CDC Global Services, our expectations with respect to the commercial launch of Mythical Legends and LOTRO at CDC Games, our expectations regarding our continued partnership with Turbine, Inc., our expectations regarding future metrics for Yulgang, our expectations regarding our new proposed complaint in our litigation with Evolution, as well as our plans to file a motion for summary judgment in that matter, our beliefs regarding our significant investments in our businesses’ operations and the impact thereof, our beliefs regarding our strategic investments and initiatives, and our strategies, and the potential impact and benefit thereof, our beliefs regarding the creation of shareholder value, our beliefs regarding the value of our core assets, our plans with respect to the repurchase of additional shares, beliefs and expectations about any potential investments or transactions that we may undertake, our beliefs regarding any future revenue or business growth, recurring revenues, and other metrics, our expectations regarding any future or planned game testing or launches, including LOTRO, our beliefs regarding the value of our shares and our sum of parts valuation approach, our beliefs about our plans and strategies and factors that may affect them, our beliefs regarding any amounts, projections of performance and other matters relating to any future period, our goals with respect to levels of recurring revenue, our plans relating to joint ventures or other partnerships, our expectations regarding future expansion in China, our Silk Road initiative and the potential benefits to us, our customers and shareholders, our beliefs regarding the utility of the Non-GAAP and pro forma financial information provided herein, and other statements that are not historical fact, the achievement of which involve risks, uncertainties and assumptions. These statements are based on management's current expectations and are subject to risks and uncertainties and changes in circumstances. There are important factors that could cause actual results to differ materially from those anticipated in the forward looking statements, including the following: (a) the ability to realize strategic objectives by taking advantage of market opportunities in targeted geographic markets; (b) the risk of significant liability and losses from any litigation matters or other disputes in which we or any of our subsidiaries may be involved, including the litigation between Sunshine Mills, Inc. and Ross Systems and the litigation between Evolution Capital Management and CDC Corporation; (c) risks related to the potential impact of any litigation matters, including the Sunshine Mills or Evolution matters, on our business, operations and financial condition and those of our subsidiaries; (d) the ability to make changes in business strategy, development plans and product offerings to respond to the needs of current, new and potential customers, suppliers and strategic partners; (e) the effects of restructurings and rationalization of operations in our companies; (f) the ability to address technological changes and developments including the development and enhancement of products; (g) the ability to develop and market successful products and services; (h) the entry of new competitors and their technological advances; (i) the need to develop, integrate and deploy enterprise software applications to meet customer's requirements; (i) the possibility of development or deployment difficulties or delays; (k) the dependence on customer satisfaction with the company's games, software products and services; (l) continued commitment to the deployment of the products, including enterprise software solutions; (m) risks involved in developing software solutions and integrating them with third-party software and services; (n) the continued ability of the company's products and services to address client-specific requirements; (o) demand for and market acceptance of new and existing enterprise software and services and the positioning of the company's solutions; (p) risks associated with our convertible debt; (q) the outcome of any litigation in which we are a party; and (r) the ability of staff to operate the enterprise software and extract and utilize information from the company's products and services. If any such risks or uncertainties materialize or if any of the assumptions proves incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make. Also, the results and benefits experienced by customers and users set forth in this press release may differ from those of other users and customers. Further information on risks or other factors that could cause results to differ is detailed in filings or submissions with the United States Securities and Exchange Commission made by CDC Corporation in its Annual Report on Form 20-F for the year ended December 31, 2009, filed with the SEC on June 30, 2010. All forward-looking statements included in this press release are based upon information available to management as of the date of the press release, and you are cautioned not to place undue reliance on any forward looking statements which speak only as of the date of this press release. The company assumes no obligation to update or alter the forward looking statements whether as a result of new information, future events or otherwise. Historical results are not indicative of future performance. For these and other reasons, investors are cautioned not to place undue reliance upon any forward-looking statement in this press release.

CDC Corporation Consolidated Balance Sheets (Amounts in thousands of U.S. dollars except share and per share data)     Table 1 December 31, December 31,  

2009 (b)

 

  2010   ASSETS Audited Unaudited Current assets: Cash $ 115,290 $ 99,429 Restricted cash 790 140

Accounts receivable (net of allowance of $8,839 and $6,302 at December 31, 2009 and 2010, respectively)

58,883 54,044 Investments 2,418 985 Deferred tax assets 5,387 5,679 Prepayments and other current assets   13,276     15,170   Total current assets 196,044 175,447   Property and equipment, net 13,500 9,808 Goodwill 177,858 191,341 Intangible assets, net 94,859 78,163 Investments 12,863 11,943 Equity investments 11,360 10,695 Deferred tax assets 35,983 30,092 Other assets   4,220     6,968   Total assets $ 546,687   $ 514,457     LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities: Accounts payable $ 22,513 $ 23,367 Purchase consideration payables 2,457 34 Income tax payable 2,867 3,440 Accrued liabilities 37,382 43,055 Restructuring accruals 2,061 1,605 Short-term loans 12,539 15,078 Convertible notes 52,320 58,195 Deferred revenue 59,975 59,271 Deferred tax liabilities   1,797     1,427   Total current liabilities 193,911 205,472   Deferred tax liabilities 23,985 20,677 Long-term debt - 238 Purchase consideration payables 810 1,563 Other liabilities   14,584     14,695   Total liabilities 233,290 242,645   Shareholders’ equity:

Preferred shares, $0.003 par value; 1,666,667 shares authorized, no shares issued

- -

Class A common shares, $0.00075 par value; 266,666,667 shares authorized; 39,492,990 and 39,616,132 shares issued as of December 31, 2009 and 2010, respectively; 35,253,982 and 35,140,879 shares outstanding as of December 31, 2009 and 2010, respectively

28 28 Additional paid-in capital 740,981 747,978

Common stock held in treasury; 4,239,008 and 4,475,253 shares at December 31, 2009 and 2010, respectively

(58,091 ) (59,445 ) Accumulated deficit (427,169 ) (467,769 ) Accumulated other comprehensive income   18,796     22,211   Total shareholders’ equity 274,545 243,003   Noncontrolling interest   38,852     28,809   Total equity   313,397     271,812   Total liabilities and shareholders’ equity $ 546,687   $ 514,457   CDC Corporation Unaudited Consolidated Statement of Operations (Amounts in thousands of U.S. dollars except share and per share data)   Table 2 Three months ended September 30, December 31,   2010     2010   REVENUE: CDC Software $ 53,007 $ 56,750 CDC Global Services 15,870 14,639 CDC Games 6,384 7,251 China.com   3,095     4,441   Total revenue 78,356 83,081   COST OF REVENUE: CDC Software 23,517 25,438 CDC Global Services 13,224 12,422 CDC Games 4,976 4,726 China.com   1,342     1,918   Total cost of revenue   43,059     44,504     Gross profit 35,297 38,577 Gross margin % 45 % 46 %   OPERATING EXPENSES: Sales and marketing expenses 12,172 14,027 Research and development expenses 6,868 7,257 General and administrative expenses 18,277 18,377 Exchange gain (1,139 ) (543 ) Amortization expenses 2,195 2,090 Restructuring and other charges   (18 )   17,515   Total operating expenses   38,355     58,723     Operating loss (3,058 ) (20,146 ) Operating margin % -4 % -24 %   Other loss, net   (1,526 )   (2,534 )   Loss before income taxes (4,584 ) (22,680 ) Income tax expense   (1,409 )   (659 )   Net loss (5,993 ) (23,339 ) Net (income) loss attributable to noncontrolling interest   (107 )   309     Net loss attributable to controlling interest $ (6,100 ) $ (23,030 )   Basic and diluted loss per share from operations attributable to controlling interest (1) $ (0.18 ) $ (0.65 )   Basic and diluted loss per share attributable to controlling interest (1) $ (0.18 ) $ (0.65 )   Weighted average number of common shares outstanding - basic 35,162,009 35,207,424   Weighted average number of common shares outstanding - diluted 35,162,009 35,207,424   (1) Refer to "Unaudited Basic and Diluted Earnings (Loss) Per Share Computation" schedule for calculation of earnings per share amounts. CDC Corporation Unaudited Consolidated Statement of Operations (Amounts in thousands of U.S. dollars except share and per share data)     Table 3 Three months ended

December 31,

  2009     2010   REVENUE: CDC Software $ 54,326 $ 56,750 CDC Global Services 17,568 14,639 CDC Games 7,011 7,251 China.com   4,068     4,441   Total revenue 82,973 83,081   COST OF REVENUE: CDC Software 23,857 25,438 CDC Global Services 14,137 12,422 CDC Games 8,939 4,726 China.com   1,397     1,918   Total cost of revenue   48,330     44,504     Gross profit 34,643 38,577 Gross margin % 42 % 46 %   OPERATING EXPENSES: Sales and marketing expenses 12,221 14,027 Research and development expenses 5,311 7,257 General and administrative expenses 17,295 18,377 Exchange gain (1,395 ) (543 ) Amortization expenses 2,033 2,090 Restructuring and other charges   2,178     17,515   Total operating expenses   37,643     58,723     Operating loss (3,000 ) (20,146 ) Operating margin % -4 % -24 %   Other income (loss), net   3,334     (2,534 )   Loss before income taxes 334 (22,680 ) Income tax expense   (4,331 )   (659 )   Net loss (3,997 ) (23,339 ) Net income (loss) attributable to noncontrolling interest   (680 )   309     Net loss attributable to controlling interest $ (4,677 ) $ (23,030 )   Basic and diluted loss per share from continuing operations attributable to controlling interest (1) $ (0.14 ) $ (0.65 )   Basic and diluted loss per share attributable to controlling interest (1) $ (0.13 ) $ (0.65 )   Weighted average number of common shares outstanding - basic 35,350,423 35,207,424   Weighted average number of common shares outstanding - diluted 36,106,591 35,207,424   (1) Refer to "Unaudited Basic and Diluted Earnings (Loss) Per Share Computation" schedule for calculation of earnings per share amounts. CDC Corporation Unaudited Consolidated Statement of Operations (Amounts in thousands of U.S. dollars except share and per share data)   Table 4 Twelve months ended

December 31,

  2009     2010   REVENUE: CDC Software $ 203,899 $ 212,876 CDC Global Services 75,149 62,717 CDC Games 28,890 28,714 China.com   12,180     13,532   Total revenue 320,118 317,839   COST OF REVENUE: CDC Software 93,183 96,535 CDC Global Services 62,294 51,574 CDC Games 24,431 20,520 China.com   5,077     6,307   Total cost of revenue   184,985     174,936     Gross profit 135,133 142,903 Gross margin % 42 % 45 %   OPERATING EXPENSES: Sales and marketing expenses 46,380 51,763 Research and development expenses 18,019 27,876 General and administrative expenses 66,080 66,938 Exchange gain (3,427 ) (2,240 ) Amortization expenses 7,927 8,565 Restructuring and other charges   5,510     18,213   Total operating expenses   140,489     171,115     Operating loss (5,356 ) (28,212 ) Operating margin % -2 % -9 %   Other income (loss), net   30,160     (7,027 )   Income (loss) before income taxes 24,804 (35,239 ) Income tax expense   (11,438 )   (4,847 )   Income (loss) from continuing operations 13,366 (40,086 ) Loss from operations of discontinued subsidiaries, net of tax   -     -     Net income (loss) 13,366 (40,086 ) Net (income) loss attributable to noncontrolling interest   (1,505 )   (514 )   Net income (loss) attributable to controlling interest $ 11,861   $ (40,600 )   Basic and diluted earnings (loss) per share from continuing operations attributable to controlling interest (1) $ 0.29   $ (1.15 )   Basic and diluted earnings (loss) per share attributable to controlling interest (1) $ 0.29   $ (1.15 )   Weighted average number of common shares outstanding - basic 35,402,831 35,227,368   Weighted average number of common shares outstanding - diluted 36,146,564 35,227,368 . (1) Refer to "Unaudited Basic and Diluted Earnings (Loss) Per Share Computation" schedule for calculation of earnings per share amounts. CDC Corporation Unaudited Consolidated Statement of Cash Flows (Amounts in thousands of U.S. dollars)     Table 5 Three months ended September 30, December 31,   2010     2010   OPERATING ACTIVITIES: Net loss $ (5,993 ) $ (23,339 ) Adjustments to reconcile net loss to net cash provided by operating activities Loss on disposal of property and equipment 133 196 Gain on disposal of available-for-sale securities (373 ) (317 ) Bad debt expense 774 1,405 Amortization expense 6,813 5,917 Depreciation expense 1,695 1,617 Stock compensation expenses 1,464 1,270 Deferred income tax provision (2,455 ) 2,133 Exchange gain (1,139 ) (543 ) Non-cash restructuring and other charges 58 6,698 Intangibles impairment - 9,881 Cost investments impairment - 936 Amortization of debt issuance costs 87 87 Interest expense 1,535 1,052 Changes in operating assets and liabilities: Accounts receivable 5,214 1,963 Deposits, prepayments and other receivables (782 ) 1,403 Other assets 200 (1,674 ) Accounts payable 49 2,746 Accrued liabilities (1,915 ) 282 Deferred revenue (2,404 ) 1,917 Income tax payable 3,395 (1,999 ) Other liabilities   572     (2,686 ) Net cash provided by operating activities   6,928     8,945     INVESTING ACTIVITIES: Acquisition, net of cash acquired 216 (16 ) Payments for prior year acquisitions (780 ) (320 ) Purchase of property, plant & equipment (670 ) (304 ) Purchases of intangible assets (9 ) - Disposal (acquisition) of cost method investments 372 2,386 Investment in cost method investees (148 ) 1,057 Proceeds from disposal of available-for-sale securities   -     (1,427 ) Net cash provided by (used in) investing activities   (1,019 )   1,376     FINANCING ACTIVITIES: Issuance of share capital, net of offering costs 178 (178 ) Short-term borrowings (repayments) (7,208 ) (357 ) Payment for capital lease obligations (92 ) (24 ) Purchase of CDC Software shares (1,712 ) (2,214 ) Purchases of treasury stock (843 ) 187 Dividend distribution by China.com (2,553 ) (369 ) Other financing   1,266     (1,395 ) Net cash used in financing activities   (10,964 )   (4,350 )   Effect of exchange differences on cash   2,318     2,539     Net increase (decrease) in cash (2,737 ) 8,511 Cash at beginning of period   93,655     90,918     Cash at end of period $ 90,918   $ 99,429   CDC Corporation Consolidated Statement of Cash Flows (Amounts in thousands of U.S. dollars)         Table 6 Three months ended December 31, Twelve months ended December 31,   2009     2010       2009     2010   Unaudited Unaudited Audited Unaudited OPERATING ACTIVITIES: Net income (loss) $ (3,997 ) $ (23,339 ) $ 13,366 $ (40,086 ) Adjustments to reconcile net income to net cash provided by operating activities Loss on disposal of property and equipment 65 196 291 346 Loss on disposal of available-for-sale securities (2,202 ) (317 ) (2,173 ) (1,669 ) Gain on equity investments 512 - 512 - Gain on purchase of convertible notes (38,184 ) - (38,184 ) - Bad debt expense 1,274 1,405 2,358 2,557 Amortization expense 7,104 5,917 27,519 26,501 Depreciation expense 1,710 1,617 6,985 6,730 Stock compensation expenses 2,324 1,270 6,539 5,382 Deferred income tax provision 1,776 2,133 8,685 1,971 Exchange gain (1,395 ) (543 ) (3,427 ) (2,240 ) Intangibles impairment - 9,881 - 9,881 Cost investments impairment 185 936 185 936 Non-cash restructuring and other charges 731 6,698 4,063 7,396 Amortization of debt issuance costs and debt discount on convertible notes (2,257 ) 87 2,055 232 Fair market value adjustment on convertible notes 38,687 - 5,012 - Interest income 51 - - - Interest expense 849 1,052 849 5,752 Changes in operating assets and liabilities: Accounts receivable (9,040 ) 1,963 16,710 6,082 Deposits, prepayments and other receivables 1,650 1,403 408 (210 ) Other assets (533 ) (1,674 ) (1,145 ) (1,260 ) Accounts payable (414 ) 2,746 (1,831 ) (582 ) Accrued liabilities 2,795 282 (9,996 ) (5,700 ) Deferred revenue 2,485 1,917 (5,960 ) (3,108 ) Income tax payable 1,800 (1,999 ) (1,533 ) 595 Other liabilities   (562 )   (2,686 )   (441 )   (1,903 ) Net cash provided by operating activities   5,414     8,945     30,847     17,603     INVESTING ACTIVITIES: Acquisitions, net of cash acquired (25,532 ) (16 ) (26,856 ) (23,121 ) Payments for prior year acquisitions - (320 ) (944 ) (3,200 ) Purchase of property, plant & equipment (349 ) (304 ) (3,371 ) (1,405 ) Purchases of intangible assets 202 - (51 ) (1,222 ) Payment for capitalized software (556 ) - (3,556 ) - Disposal (acquisition) of cost method investments - 2,386 (1,226 ) 4,152 Purchase of available-for-sale securities (803 ) - (803 ) (688 ) Investment in cost method investees - 1,057 (38 ) (1,011 ) Proceeds from disposal of available-for-sale securities 7,225 (1,427 ) 33,577 - Change in restricted cash   (160 )   -     3,502     686   Net cash provided by (used in) investing activities   (19,973 )   1,376     234     (25,809 )   FINANCING ACTIVITIES: Issuance of share capital, net of offering costs 184 (178 ) 52,728 -

Proceeds from bank loans

1,027

-

1,027 - Short-term borrowings (repayments) (4,601 ) (357 ) (12,469 ) 2,322 Purchase of convertible notes (1,050 ) - (101,721 ) - Debt issuance costs - - - (1,389 ) Payment for capital lease obligations (109 ) (24 ) (569 ) (523 ) Purchase of CDC Software shares (969 ) (2,214 ) (969 ) (6,839 ) Purchases of treasury stock (623 ) 187 (1,973 ) (1,354 ) Dividend distribution by China.com (5,454 ) (369 ) (18,972 ) (2,922 ) Other financing   -     (1,395 )   -     (129 ) Net cash used in financing activities   (11,595 )   (4,350 )   (82,918 )   (10,834 )   Effect of exchange differences on cash   (119 )   2,539     1,434     3,178     Net increase (decrease) in cash (26,273 ) 8,511 (50,403 ) (15,861 ) Cash at beginning of period   141,563     90,918     165,693     115,290     Cash at end of period $ 115,290   $ 99,429   $ 115,290   $ 99,429   CDC Corporation Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Table 7 Three months ended September 30, December 31,   2010     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating loss $ (3,058 ) $ (20,146 ) Add back restructuring and other charges (18 ) 17,515 Add back depreciation expense 1,695 1,617 Add back amortization expense 2,194 2,090 Add back amortization expense included in cost of revenue 4,619 3,827 Add back stock compensation expenses 1,464 1,270 Subtract exchange gain (1,139 ) (543 ) Add back deferred revenue grind (1)   1,194     831   Adjusted EBITDA $ 6,951   $ 6,461   Adjusted EBITDA margin % 9 % 8 %   CDC Software Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended September 30, December 31,   2010     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating income (loss) $ 3,852 $ (2,459 ) Add back restructuring and other charges (376 ) 4,952 Add back depreciation expense 869 815 Add back amortization expense 1,350 1,408 Add back amortization expense included in cost of revenue 3,515 3,318 Add back stock compensation expenses 764 619 Subtract exchange gain (1,105 ) (444 ) Add back deferred revenue grind (1)   1,194     831   Adjusted EBITDA $ 10,063   $ 9,040   Adjusted EBITDA margin % 19 % 16 %   CDC Global Services Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended September 30, December 31,   2010     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating loss $ (2,598 ) $ (14,732 ) Add back restructuring and other charges 1,457 12,666 Add back depreciation expense 84 88 Add back amortization expense 605 446 Add back amortization expense included in cost of revenue 4 8 Add back stock compensation expenses 135 138 Add back exchange loss   1     1   Adjusted EBITDA $ (312 ) $ (1,385 ) Adjusted EBITDA margin % -2 % -9 %   CDC Games Corporation Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended September 30, December 31,   2010     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating income (loss) $ (1,061 ) $ 1,237 Add back restructuring and other charges 139 311 Add back depreciation expense 709 674 Add back amortization expense included in cost of revenue 1,100 501 Add back stock compensation expenses   165     154   Adjusted EBITDA $ 1,052   $ 2,877   Adjusted EBITDA margin % 16 % 40 %   CDC China.com Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended September 30, December 31,   2010     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating income (loss) $ (515 ) $ 234 Add back depreciation expense 33 40 Add back stock compensation expenses   210     169   Adjusted EBITDA $ (272 ) $ 443   Adjusted EBITDA margin % -9 % 10 %   Corporate Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended September 30, December 31,   2010     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA from operations Operating loss $ (2,736 ) $ (4,426 ) Add back restructuring and other charges (1,238 ) (414 ) Add back amortization expense 239 236 Add back stock compensation expenses 190 190 Subtract exchange gain   (35 )   (100 ) Adjusted EBITDA $ (3,580 ) $ (4,514 )     (1) Deferred revenue grind represents the fair value adjustment required to reduce the historical deferred revenue liabilities from acquisitions to the fair value of the Company’s legal performance obligations plus a normal profit margin based on fulfillment effort. CDC Corporation Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)         Table 8 Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating loss $ (3,000 ) $ (20,146 ) $ (5,356 ) $ (28,212 ) Add back restructuring and other charges 2,178 17,515 5,510 18,213 Add back depreciation expense 1,785 1,617 6,985 6,730 Add back amortization expense 2,033 2,090 7,927 8,565 Add back amortization expense included in cost of revenue 8,189 3,827 22,710 17,936 Add back stock compensation expenses 2,414 1,270 6,539 5,382 Subtract exchange gain (1,395 ) (543 ) (3,427 ) (2,240 ) Add back deferred revenue grind (1)   632     831     632     4,672   Adjusted EBITDA (2) $ 12,836   $ 6,461   $ 41,520   $ 31,046   Adjusted EBITDA margin % 15 % 8 % 13 % 10 %   CDC Software Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating income (loss) $ 5,889

 

$ (2,459 ) $ 27,656

 

$ 7,891 Add back restructuring and other charges 1,176

 

4,952 3,351

 

5,378 Add back depreciation expense 750 815 3,122 3,335 Add back amortization expense 1,151 1,408 4,533 5,334 Add back amortization expense included in cost of revenue 3,584 3,318 14,408 14,115 Add back stock compensation expenses 909 619 2,041 2,379 Subtract exchange gain (39 ) (444 ) (2,093 ) (2,081 ) Add back deferred revenue grind (1)   632     831     632     4,672   Adjusted EBITDA (2) $ 14,052   $ 9,040   $ 53,650   $ 41,023   Adjusted EBITDA margin % 26 % 16 % 26 % 19 %   CDC Global Services Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating loss $ (2,612 ) $ (14,732 ) $ (9,559 ) $ (20,164 ) Add back restructuring and other charges 1,523 12,666 6,776 17,911 Add back depreciation expense 99 88 319 328 Add back amortization expense 645 446 2,425 2,337 Add back amortization expense included in cost of revenue 1 8 18 13 Add back stock compensation expenses 267 138 857 473 Add back exchange loss   -     1     6     3   Adjusted EBITDA $ (77 ) $ (1,385 ) $ 842   $ 901   Adjusted EBITDA margin % 0 % -9 % 1 % 1 %   CDC Games Corporation Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating income (loss) $ (5,320 ) $ 1,237 $ (11,203 ) $ (1,806 ) Add back restructuring and other charges 20 311 627 138 Add back depreciation expense 793 674 3,124 2,859 Add back amortization expense - - 22 - Add back amortization expense included in cost of revenue 4,604 501 8,284 3,808 Add back stock compensation expenses   366     154     1,126     657   Adjusted EBITDA $ 463   $ 2,877   $ 1,980   $ 5,656   Adjusted EBITDA margin % 7 % 40 % 7 % 20 %   CDC China.com Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating income (loss) $ 1,683 $ 234 $ (381 ) $ (1,192 ) Add back depreciation expense 129 40 367 190 Add back stock compensation expenses 353 169 1,125 614 Subtract exchange loss (gain)   (1,356 )   -     (1,356 )   -   Adjusted EBITDA $ 809   $ 443   $ (245 ) $ (388 ) Adjusted EBITDA margin % 20 % 10 % -2 % -3 %   Corporate Unaudited Reconciliation From GAAP Results to Adjusted EBITDA (Amounts in thousands of U.S. dollars)   Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010   (a) Reconciliation from GAAP results to Adjusted EBITDA Operating loss $ (2,640 ) $ (4,426 ) $ (11,869 ) $ (12,941 ) Add back restructuring and other charges (542 ) (414 ) (5,244 ) (5,214 ) Add back depreciation expense 14 - 53 18 Add back amortization expense 237 236 947 894 Add back stock compensation expenses 519 190 1,390 1,259 Add (subtract) exchange loss (gain)   -     (100 )   16     (162 ) Adjusted EBITDA $ (2,412 ) $ (4,514 ) $ (14,707 ) $ (16,146 )     (1) Deferred revenue grind represents the fair value adjustment required to reduce the historical deferred revenue liabilities from acquisitions to the fair value of the Company’s legal performance obligations plus a normal profit margin based on fulfillment effort. (2) Adjusted EBITDA does not include the adjustment related to capitalized software costs which are credited against research and development expenses in our consolidated statement of operations. Below is a summary of capitalized software credits for 2009 and 2010:   Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010     Subtract capitalized software credit $ (556 ) $ -   $ (3,556 ) $ -   CDC Corporation Unaudited Reconciliation From GAAP Results to Non-GAAP Net Income (Amounts in thousands of U.S. dollars)         Table 9 Three months ended December 31, September 30, December 31,   2009     2010     2010   (a) Reconciliation from GAAP net income attributable to controlling interest to Non-GAAP net income and Non-GAAP net income per share Net loss attributable to controlling interest $ (4,677 ) $ (6,100 ) $ (23,030 ) Subtract gain from operations of discontinued subsidiaries, net of tax (409 ) - - Add back restructuring and other charges 2,178 (18 ) 17,515 Add back amortization expense 2,033 2,194 2,090 Add back amortization expense included in cost of revenue 8,184 4,619 3,827 Add back stock based compensation 2,414 1,464 1,270 Subtract capitalized software credits (556 ) - - Subtract exchange gain (1,395 ) (1,139 ) (543 ) Add back deferred revenue grind 632 1,194 831 Add back non cash tax expense 3,248 493 231

Tax effect on all reconciling items @ 31%

  (4,467 )   (2,930 )   (7,915 ) Non-GAAP net income (loss) $ 7,185   $ (223 ) $ (5,724 ) Non-GAAP net income (loss) as % of revenue 9 % -2 % -7 %   Weighted average number of common shares outstanding - basic 35,350,423 35,162,009 35,207,424 Weighted average number of common shares outstanding - diluted 36,106,591 35,162,009 35,207,424   Non-GAAP net income per share - basic $ 0.20 $ (0.01 ) $ (0.16 ) Non-GAAP net income per share - diluted $ 0.20 $ (0.01 ) $ (0.16 ) CDC Corporation Unaudited Revenue Details (Amounts in thousands of U.S. dollars)                   Table 10 Three months ended December 31, 2009 CDC Software Global Services CDC Games China.com

Elimination of Intersegment Revenue

Total Segment revenue from external customers: Licenses $ 10,511 $ 106 $ - $ - $ - $ 10,617 Maintenance 25,343 - - - - 25,343 Professional services 15,800 15,971 - - - 31,771 Hardware 2,056 1,491 - - - 3,547 SaaS 616 - - - - 616 New media   -   -   7,011   4,068   -     11,079 Total consolidated revenue $ 54,326 $ 17,568 $ 7,011 $ 4,068 $ -   $ 82,973     Three months ended September 30, 2010 CDC Software Global Services CDC Games China.com Elimination of Intersegment Revenue Total Segment revenue from external customers: Licenses $ 9,006 $ 43 $ - $ - $ - $ 9,049 Maintenance 25,240 - - - - 25,240 Professional services 14,702 17,251 - - (2,750 ) 29,203 Hardware 567 1,326 - - - 1,893 SaaS 3,492 - - - - 3,492 New media   -   -   6,384   3,095   -     9,479 Total consolidated revenue $ 53,007 $ 18,620 $ 6,384 $ 3,095 $ (2,750 ) $ 78,356    

Three months ended December 31, 2010

CDC Software Global Services CDC Games China.com Elimination of Intersegment Revenue Total Segment revenue from external customers: Licenses $ 10,138 $ 8 $ - $ - $ - $ 10,146 Maintenance 26,208 - - - - 26,208 Professional services 15,520 15,893 - - (2,922 ) 28,491 Hardware 1,230 1,660 - - - 2,890 SaaS 3,654 - - - - 3,654 New media   -   -   7,251   4,441   -     11,692 Total consolidated revenue $ 56,750 $ 17,561 $ 7,251 $ 4,441 $ (2,922 ) $ 83,081     CDC Corporation Unaudited Revenue Details (Amounts in thousands of U.S. dollars)   Twelve months ended December 31, 2009 CDC Software Global Services CDC Games China.com

Elimination of Intersegment Revenue

 

Total Segment revenue from external customers: Licenses $ 33,085 $ 1,269 $ - $ - $ - $ 34,354 Maintenance 99,775 - - - - 99,775 Professional services 66,666 69,251 - - - 135,917 Hardware 3,757 4,629 - - - 8,386 SaaS 616 - - - - 616 New media   -   -   28,890   12,180   -     41,070 Total consolidated revenue $ 203,899 $ 75,149 $ 28,890 $ 12,180 $ -   $ 320,118     Twelve months ended December 31, 2010 CDC Software Global Services CDC Games China.com Elimination of Intersegment Revenue Total Segment revenue from external customers: Licenses $ 35,884 $ 136 $ - $ - $ - $ 36,020 Maintenance 100,184 - - - - 100,184 Professional services 62,144 64,897 - - (7,469 ) 119,572 Hardware 3,845 5,153 - - - 8,998 SaaS 10,819 - - - - 10,819 New media   -   -   28,714   13,532   -     42,246 Total consolidated revenue $ 212,876 $ 70,186 $ 28,714 $ 13,532 $ (7,469 ) $ 317,839 CDC Corporation   Unaudited Reconciliation From GAAP Cash to Non-GAAP Cash (Amounts in thousands of U.S. dollars)   Table 11 December 31, (a) Non-GAAP Cash and Cash Equivalents Reconciliation 2010 Cash $ 99,429 Add restricted cash 140 Add available for sale securities - current 985 Investments (1)   11,268 Non-GAAP cash and cash equivalents $ 111,822   (1) - Excludes investments of $675 in franchise and strategic cloud investment partners at December 31, 2010. CDC Corporation Unaudited Basic and Diluted Earnings (Loss) Per Share Computation (Amounts in thousands of U.S. dollars except share and per share data)         Table 12 Three months ended

December 31,

Twelve months ended

December 31,

  2009     2010     2009     2010  

Numerator for earnings (loss) attributable to controlling interest per common share:

Net income (loss) $ (4,407 ) $ (23,030 ) $ 13,366 $ (40,086 )

Net adjustments for (income) loss attributable to noncontrolling interest and dilutive effect of subsidiary issued stock (1)

 

  (679 )   308     (1,505 )   (514 ) Adjusted income (loss) (5,086 ) (22,722 ) 11,861 (40,600 ) Amount allocated to convertible notes (2)   -     -     (1,208 )   -   Net income (loss) attributable to controlling

interest

$ (5,086 ) $ (22,722 ) $ 10,653   $ (40,600 )   Numerator for earnings (loss) attributable to controlling interest per common share:       Net income (loss) attributable to controlling interest $ (4,677 ) $ (22,722 ) $ 10,653   $ (40,600 )   Denominator: Weighted average number of common shares outstanding - basic 35,350,423 35,207,424 35,402,831 35,227,368

Employee compensation related to common shares including stock

options

  756,168     -     743,733     -   Weighted average number of common shares outstanding - diluted   36,106,591     35,207,424     36,146,564     35,227,368     Per share amounts:

Earnings (loss) attributable to controlling interest per common share - basic and dilutive

 

$ (0.14 ) $ (0.65 ) $ 0.29   $ (1.15 )

Earnings (loss) attributable to controlling interest per common share - basic and dilutive

 

$ (0.13 ) $ (0.65 ) $ 0.29   $ (1.15 )  

(1) Includes the dilutive effects of subsidiary-issued stock-based awards, if any.

(2) Income has been allocated to common stock and convertible notes based on their respective rights to share in dividends. In accordance with FASB Accounting Standards Codification 260, "Earnings Per Share" the Company's convertible notes meet the definition of participating securities and are included in the basic earnings per share using the two-class stock method and in diluted earnings per share using the more dilutive of the if-converted method or two-class stock method.

CDC Corporation Unaudited Reconciliation of GAAP Revenue to Non-GAAP Revenue (Amounts in thousands of U.S. dollars)       Table 13 Three Months Ended December 31, 2009 GAAP Revenue Non-GAAP Adjustment (1) Non-GAAP Revenue   Software $ 54,326 $ 632 $ 54,958 Global Services 17,568 - 17,568 CDC Games 7,011 - 7,011 China.com   4,068   -   4,068 Total revenue $ 82,973 $ 632 $ 83,605     Three Months Ended September 30, 2010 GAAP Revenue Non-GAAP Adjustment (1) Non-GAAP Revenue   Software $ 53,007 $ 1,194 $ 54,201 Global Services 15,870 - 15,870 CDC Games 6,384 - 6,384 China.com   3,095   -   3,095 Total revenue $ 78,356 $ 1,194 $ 79,550     Three Months Ended December 31, 2010 GAAP Revenue Non-GAAP Adjustment (1) Non-GAAP Revenue   Software $ 56,750 $ 831 $ 57,581 Global Services 14,639 - 14,639 CDC Games 7,251 - 7,251 China.com   4,441   -   4,441 Total revenue $ 83,081 $ 831 $ 83,912     (1) Non-GAAP adjustment represents deferred revenue grind adjustment required to reduce the historical deferred revenue liabilities from acquisitions to the fair value of the Company’s legal performance obligations plus a normal profit margin based on fulfillment effort. CDC Corporation Unaudited Reconciliation of GAAP Revenue to Non-GAAP Revenue (Amounts in thousands of U.S. dollars)       Table 14 Twelve Months Ended December 31, 2009 GAAP Revenue Non-GAAP Adjustment (1) Non-GAAP Revenue   Software $ 203,899 $ 632 $ 204,531 Global Services 75,149 - 75,149 CDC Games 28,890 - 28,890 China.com   12,180   -   12,180 Total revenue $ 320,118 $ 632 $ 320,750     Twelve Months Ended December 30, 2010 GAAP Revenue Non-GAAP Adjustment (1) Non-GAAP Revenue   Software $ 212,876 $ 4,672 $ 217,548 Global Services 62,717 - 62,717 CDC Games 28,714 - 28,714 China.com   13,532   -   13,532 Total revenue $ 317,839 $ 4,672 $ 322,511       (1) Non-GAAP adjustment represents deferred revenue grind adjustment required to reduce the historical deferred revenue liabilities from acquisitions to the fair value of the Company’s legal performance obligations plus a normal profit margin based on fulfillment effort.